Alkamides from Echinacea disrupt the fungal cell wall-membrane complex.

Phytomedicine

Department of Biology, Carleton University, 1125 Colonel By Drive, Ottawa, Ontario K1S 5B6, Canada. Electronic address:

Published: March 2014

We tested the hypothesis that alkamides from Echinacea exert antifungal activity by disrupting the fungal cell wall/membrane complex. Saccharomyces cerevisiae cells were treated separately with each of seven synthetic alkamides found in Echinacea extracts. The resulting cell wall damage and cell viability were assessed by fluorescence microscopy after mild sonication. Membrane disrupting properties of test compounds were studied using liposomes encapsulating carboxyfluorescein. Negative controls included hygromycin and nourseothricin (aminoglycosides that inhibit protein synthesis), and the positive control used was caspofungin (an echinocandin that disrupts fungal cell walls). The results show that yeast cells exposed to sub-inhibitory concentrations of each of the seven alkamides and Echinacea extract exhibit increased frequencies of cell wall damage and death that were comparable to caspofungin and significantly greater than negative controls. Consistent with effects of cell wall damaging agents, the growth inhibition by three representative alkamides tested and caspofungin, but not hygromycin B, were partially reversed in sorbitol protection assays. Membrane disruption assays showed that the Echinacea extract and alkamides have pronounced membrane disruption activity, in contrast to caspofungin and other controls that all had little effect on membrane stability. A Quantitative Structure-Activity Relationship (QSAR) analysis was performed to study the effect of structural substituents on the antifungal activity of the alkamides. Among the set studied, diynoic alkamides showed the greatest antifungal and cell wall disruption activities while an opposite trend was observed in the membrane disruption assay where the dienoic group was more effective. We propose that alkamides found in Echinacea act synergistically to disrupt the fungal cell wall/membrane complex, an excellent target for specific inhibition of fungal pathogens. Structure-function relationships provide opportunities for synthesis of alkamide analogs with improved antifungal activities.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phymed.2013.10.025DOI Listing

Publication Analysis

Top Keywords

alkamides echinacea
20
fungal cell
16
cell wall
16
membrane disruption
12
alkamides
9
cell
9
disrupt fungal
8
antifungal activity
8
cell wall/membrane
8
wall/membrane complex
8

Similar Publications

Critical analysis of Echinacea preparations marketed in Germany.

Naunyn Schmiedebergs Arch Pharmacol

November 2024

Institute of Pharmacology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Article Synopsis
  • - Colds lead to significant work incapacity in 2023, impacting the German economy, with Echinacea products being popular as immune boosters and gaining attention during the COVID-19 pandemic.
  • - A study examined 22 Echinacea herbal preparations, highlighting inconsistencies in their ingredients and formulations, despite their similar market presentation.
  • - To better match clinical research with real-world products, new studies should analyze the actual compositions of these preparations and consider factors like dosage and work incapacity as outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • Echinacea species are known for their immune-boosting, antibacterial, and antiviral effects, and this review examines how their extracts influence both innate and adaptive immune responses during infections.
  • Key bioactive compounds like alkamides and flavonoids enhance the activity of immune cells, improve cytokine production, and help fight against various bacterial and viral pathogens.
  • The review also highlights echinacea's potential role as a complementary treatment, discusses challenges in standardizing herbal content, and suggests future research directions, including clinical trials.
View Article and Find Full Text PDF

Dicaffeoylquinic acids (DCQAs) are polyphenolic compounds found in various medicinal plants such as and whose multi-constituent extracts are used worldwide to treat respiratory diseases. Besides triterpenes, saponins, alkamides, and other constituents, DCQAs are an important group of substances for the pharmacological activity of plant-derived extracts. Therefore, the pharmacological properties of DCQAs have been studied over the last decades, suggesting antioxidative, anti-inflammatory, antimicrobial, hypoglycaemic, cardiovascular protective, neuroprotective, and hepatoprotective effects.

View Article and Find Full Text PDF

Echinacea purpurea against neuropathic pain: Alkamides versus polyphenols efficacy.

Phytother Res

May 2023

Research and Innovation Center in Phytotherapy and Integrated Medicine (CERFIT), Referring Center for Phytotherapy, Tuscany Region, Careggi University Hospital, Florence, Italy.

Chemotherapy-induced neuropathy represents the main dose-limiting toxicity of several anticancer drugs, such as oxaliplatin, leading to chronic pain and an impairment of the quality of life. Echinacea purpurea n-hexane extract (EP -R ; rich in alkamides) and butanolic extract (EP -R ; rich in polyphenols) have been characterized and tested in an in vivo model of oxaliplatin-induced neuropathic pain, addressing the endocannabinoid system with alkamides and counteracting the redox imbalance with polyphenols. Thermal hypersensitivity was evaluated by the Cold Plate test.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!